Although prominent FRAT/GBP exhibits a limited degree of homology to Axin, the bindingsites on GSK3 for FRAT/GBP and Axin may overlap to prevent the effect of FRAT/GBP in stabilizing
![](/images/gifchars/beta2.gif)
-catenin in the Wnt pathway. Using a yeast two-hybrid screen, we identified a novel protein, GSK3
![](/images/gifchars/beta2.gif)
interaction protein (GSKIP), which binds to GSK3
![](/images/gifchars/beta2.gif)
. We have defined a 25-amino acid region in theC-terminus of GSKIP that is highly similar to the GSK3
![](/images/gifchars/beta2.gif)
interaction domain (GID) of Axin. Using an invitro kinase assay, our results indicate that GSKIP is a good GSK3
![](/images/gifchars/beta2.gif)
substrate, and both the full-lengthprotein and a C-terminal fragment of GSKIP can block phosphorylation of primed and nonprimed substratesin different fashions. Similar to Axin GID
381-405 and FRATtide, synthesized GSKIPtide is also shown tocompete with and/or block the phosphorylation of Axin and
![](/images/gifchars/beta2.gif)
-catenin by GSK3
![](/images/gifchars/beta2.gif)
. Furthermore, our da
taindicate that overexpression of GSKIP induces
![](/images/gifchars/beta2.gif)
-catenin accumulation in the cytoplasm and nucleus asvisualized by immunofluorescence. A functional assay also demonstrates that GSKIP-transfected cellshave a significant effect on the transactivity of Tcf-4. Collectively, we define GSKIP as a naturally occurringprotein that is homologous with the GSK3
![](/images/gifchars/beta2.gif)
interaction domain of Axin and is able to negatively regulateGSK3
![](/images/gifchars/beta2.gif)
of the Wnt signaling pathway.